{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:13:51Z","timestamp":1787030031559,"version":"build-2736575974"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-15-00034"],"award-info":[{"award-number":["14-15-00034"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Russian Ministry of Science and Education Program","award":["0557-2016-0013"],"award-info":[{"award-number":["0557-2016-0013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The development of universal influenza vaccines has been a priority for more than 20 years. We conducted a preclinical study in ferrets of two sets of live attenuated influenza vaccines (LAIVs) expressing chimeric hemagglutinin (cHA). These vaccines contained the HA stalk domain from H1N1pdm09 virus but had antigenically unrelated globular head domains from avian influenza viruses H5N1, H8N4 and H9N2. The viral nucleoproteins (NPs) in the two sets of universal LAIV candidates were from different sources: one LAIV set contained NP from A\/Leningrad\/17 master donor virus (MDV), while in the other set this gene was from wild-type (WT) H1N1pdm09 virus, in order to better match the CD8 T-cell epitopes of currently circulating influenza A viruses. To avoid any difference in protective effect of the various anti-neuraminidase (NA) antibodies, all LAIVs were engineered to contain the NA gene of Len\/17 MDV. Na\u00efve ferrets were sequentially immunized with three doses of (i) classical LAIVs containing non-chimeric HA and NP from MDV (LAIVs (NP-MDV)); (ii) cHA-based LAIVs containing NP from MDV (cHA LAIVs (NP-MDV)); and (iii) cHA-based LAIVs containing NP from H1N1pdm09 virus (cHA LAIVs (NP-WT)). All vaccination regimens were safe, producing no significant increase in body temperature or weight loss, in comparison with the placebo group. The two groups of cHA-based vaccines induced a broadly reactive HA stalk-directed antibody, while classical LAIVs did not. A high-dose challenge with H1N1pdm09 virus induced significant pathology in the control, non-immunized ferrets, including high virus titers in respiratory tissues, clinical signs of disease and histopathological changes in nasal turbinates and lung tissues. All three vaccination regimens protected animals from clinical manifestations of disease: immunized ferrets did not lose weight or show clinical symptoms, and their fever was significantly lower than in the control group. Further analysis of virological and pathological data revealed the following hierarchy in the cross-protective efficacy of the vaccines: cHA LAIVs (NP-WT) &gt; cHA LAIVs (NP-MDV) &gt; LAIVs (NP-MDV). This ferret study showed that prototype universal cHA-based LAIVs are highly promising candidates for further clinical development.<\/jats:p>","DOI":"10.3390\/vaccines7030061","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:02:37Z","timestamp":1562583757000},"page":"61","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-1508","authenticated-orcid":false,"given":"Irina","family":"Isakova-Sivak","sequence":"first","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Matyushenko","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kotomina","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-9873","authenticated-orcid":false,"given":"Irina","family":"Kiseleva","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Krutikova","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Donina","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Rekstin","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Larionova","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Mezhenskaya","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-5033","authenticated-orcid":false,"given":"Konstantin","family":"Sivak","sequence":"additional","affiliation":[{"name":"Department of Preclinical Trials, Smorodintsev Research Institute of Influenza, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Muzhikyan","sequence":"additional","affiliation":[{"name":"Department of Preclinical Trials, Smorodintsev Research Institute of Influenza, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Katelnikova","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Microbiology, Institute of Preclinical Research Ltd., St Petersburg 188663, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Experimental Medicine, St Petersburg 197376, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12275-017-7062-7","article-title":"H5 influenza, a global update","volume":"55","author":"Harfoot","year":"2017","journal-title":"J. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3201\/eid2401.171393","article-title":"Changing Geographic Patterns and Risk Factors for Avian Influenza A(H7N9) Infections in Humans, China","volume":"24","author":"Artois","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1099\/jgv.0.000877","article-title":"Assessing evidence for avian-to-human transmission of influenza A\/H9N2 virus in rural farming communities in northern Vietnam","volume":"98","author":"Hoa","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_4","unstructured":"WHO (2018, May 22). Tables on Clinical Evaluation of Influenza Vaccines. Pandemic and Potentially Pandemic Influenza Vaccines. Available online: http:\/\/www.who.int\/entity\/immunization\/diseases\/influenza\/Table_clinical_evaluation_influenza_pandemic.xlsx?ua=1."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: Prospects for a broadly protective universal influenza vaccine","volume":"16","author":"Nabel","year":"2010","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/biot.201400393","article-title":"Emerging influenza viruses and the prospect of a universal influenza virus vaccine","volume":"10","author":"Krammer","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1016\/j.vaccine.2012.08.073","article-title":"Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16\u201317 November 2011","volume":"30","author":"Hughes","year":"2012","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The Pathway to a Universal Influenza Vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","article-title":"Universal influenza vaccines: Shifting to better vaccines","volume":"34","author":"Tsvetnitsky","year":"2016","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: Globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nachbagauer, R., Krammer, F., and Albrecht, R.A. (2018). A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study. Vaccines (Basel), 6.","DOI":"10.3390\/vaccines6030047"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2018.03.013","article-title":"Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin","volume":"518","author":"Korenkov","year":"2018","journal-title":"Virology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.copbio.2007.11.002","article-title":"Influenza virus-specific cytotoxic T lymphocytes: A correlate of protection and a basis for vaccine development","volume":"18","author":"Rimmelzwaan","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2016.00195","article-title":"Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines","volume":"7","author":"Sridhar","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14760584.2016.1115352","article-title":"Strategies towards universal pandemic influenza vaccines","volume":"15","author":"He","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4049\/jimmunol.178.2.1030","article-title":"Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus","volume":"178","author":"Powell","year":"2007","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/CVI.05116-11","article-title":"Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine","volume":"18","author":"Chirkova","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/icb.2012.78","article-title":"Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses","volume":"91","author":"Grant","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1128\/JVI.01631-14","article-title":"Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/v4091438","article-title":"Evasion of influenza A viruses from innate and adaptive immune responses","volume":"4","author":"Kreijtz","year":"2012","journal-title":"Viruses"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tan, P.T., Heiny, A.T., Miotto, O., Salmon, J., Marques, E.T., Lemonnier, F., and August, J.T. (2010). Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008754"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1016\/j.vaccine.2009.01.016","article-title":"Influenza virus CTL epitopes, remarkably conserved and remarkably variable","volume":"27","author":"Rimmelzwaan","year":"2009","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2007.03340.x","article-title":"The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro","volume":"148","author":"Berkhoff","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21645515.2017.1417713","article-title":"Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8(+) T cells more relevant to current infections","volume":"14","author":"Korenkov","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virol.2016.10.027","article-title":"Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model","volume":"500","author":"Korenkov","year":"2017","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rekstin, A., Isakova-Sivak, I., Petukhova, G., Korenkov, D., Losev, I., Smolonogina, T., Tretiak, T., Donina, S., Shcherbik, S., and Bousse, T. (2017). Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/9359276"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1242\/dmm.007823","article-title":"The ferret as a model organism to study influenza A virus infection","volume":"4","author":"Belser","year":"2011","journal-title":"Dis. Models Mech."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lu, I.N., Kirsteina, A., Farinelle, S., Willieme, S., Tars, K., Muller, C.P., and Kazaks, A. (2018). Structure and applications of novel influenza HA tri-stalk protein for evaluation of HA stem-specific immunity. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204776"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1099\/vir.0.017996-0","article-title":"PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B\/USSR\/60\/69 influenza master donor virus","volume":"91","author":"Kiseleva","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_43","first-page":"53","article-title":"Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantitation of serum antibodies to the avian influenza virus","volume":"436","author":"Pedersen","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymeth.2015.04.037","article-title":"Measuring the neutralization potency of influenza A virus hemagglutinin stalk\/stem-binding antibodies in polyclonal preparations by microneutralization assay","volume":"90","author":"He","year":"2015","journal-title":"Methods"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/CVI.00819-13","article-title":"Characterization of reverse genetics-derived cold-adapted master donor virus A\/Leningrad\/134\/17\/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model","volume":"21","author":"Chen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/10520295009110996","article-title":"A rapid one-step Mallory-Heidenhain stain for connective tissue","volume":"25","author":"Cason","year":"1950","journal-title":"Stain Technol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/mt.2016.23","article-title":"H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets","volume":"24","author":"Spijkers","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e01463-17","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Skowronski, D.M., Janjua, N.Z., De Serres, G., Sabaiduc, S., Eshaghi, A., Dickinson, J.A., Fonseca, K., Winter, A.L., Gubbay, J.B., and Krajden, M. (2014). Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092153"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1038\/srep15279","article-title":"H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Goff, P.H., Eggink, D., Seibert, C.W., Hai, R., Martinez-Gil, L., Krammer, F., and Palese, P. (2013). Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079194"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.02598-15","article-title":"Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains","volume":"90","author":"Ryder","year":"2015","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/infdis\/jir596","article-title":"Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets","volume":"204","author":"Gustin","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Isakova-Sivak, I., de Jonge, J., Smolonogina, T., Rekstin, A., van Amerongen, G., van Dijken, H., Mouthaan, J., Roholl, P., Kuznetsova, V., and Doroshenko, E. (2014). Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102339"},{"key":"ref_58","first-page":"95","article-title":"Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model","volume":"64","author":"Korenkov","year":"2018","journal-title":"Infect. Gen. Evol. J. Mol. Epidemiol. Evol. Gen. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.vaccine.2014.11.008","article-title":"Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine","volume":"33","author":"Carter","year":"2015","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2006.05.039","article-title":"Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses","volume":"24","author":"Lu","year":"2006","journal-title":"Vaccine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/s41598-018-24394-z","article-title":"Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model","volume":"8","author":"Reber","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ryan, K.A., Slack, G.S., Marriott, A.C., Kane, J.A., Whittaker, C.J., Silman, N.J., Carroll, M.W., and Gooch, K.E. (2018). Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202675"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/978-1-4939-8678-1_24","article-title":"Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection","volume":"1836","author":"DiPiazza","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fimmu.2019.00756","article-title":"Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1128\/JVI.79.17.11239-11246.2005","article-title":"Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes","volume":"79","author":"Berkhoff","year":"2005","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1128\/JVI.01001-16","article-title":"Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection","volume":"90","author":"DiPiazza","year":"2016","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2019.01.010","article-title":"Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations","volume":"25","author":"Lee","year":"2019","journal-title":"Cell Host Microbe"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/61\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:03:33Z","timestamp":1760187813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["vaccines7030061"],"URL":"https:\/\/doi.org\/10.3390\/vaccines7030061","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]}}}